
The results of recent clinical trials have demonstrated that cancer vaccines continue to struggle to achieve tangible clinical benefits as zzso zzso abnormalities in the immune system hamper zzso T cell responses limiting the effectiveness of cancer zzso Recently, evidence has been mounting to suggest that zzso has the possibility of achieving better success when used in combination with conventional zzso In clinical trials, immune responses zzso by cancer vaccines appear to augment the effectiveness of subsequent conventional cancer zzso 

